Thursday, July 23, 2026
6:00 – 6:30 p.m. ET | Registration & dinner
6:30 – 8:00 p.m. ET | CME presentation & dessert
The Westin New York at Times Square
270 W 43rd St
New York, NY 10036
Meeting room: Broadway Ballroom (3rd Floor)
PROGRAM FEATURES
1.5 CME/CNE CREDITS
Complimentary Dinner
PRESENTING FACULTY
 |
Michio Hirano, MD Professor of Neurology Chief, Division of Neuromuscular Medicine Columbia University Irving Medical Center New York, NY |
PROGRAM OVERVIEW
This Live Summit Series will provide a practical overview of the evolving diagnostic and treatment landscape for thymidine kinase 2 deficiency (TK2d). Insights from expert faculty will help translate current evidence into actionable strategies for recognizing the clinical features of TK2d, establishing timely diagnoses, and integrating molecular genetic testing into clinical practice. The program will review current and emerging therapeutic approaches and discuss how clinical data can be applied to inform patient management. Through interactive case-based learning, faculty-led discussions, and peer-to-peer exchange, participants will gain practical tools and perspectives to support the care of patients with TK2d.
TARGET AUDIENCE
This activity is designed to meet the educational needs of neuromuscular specialists, general neurologists, pediatric neurologists, pulmonologists, NPs, and PAs involved in the diagnosis, treatment, or management of TK2d.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Utilize diagnostic criteria and clinical characteristics to identify TK2d in patients
- Integrate molecular genetic testing into routine clinical practice to confirm diagnoses of TK2d
- Apply clinical data for current and emerging therapies to inform treatment strategies
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
